Coppell Advisory Solutions LLC Ardelyx, Inc. Transaction History
Coppell Advisory Solutions LLC
- $680 Billion
- Q3 2024
A detailed history of Coppell Advisory Solutions LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 3,556 shares of ARDX stock, worth $17,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,556
Previous 2,754
29.12%
Holding current value
$17,673
Previous $20.4 Million
15.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
220Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$107 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$87.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$67.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$60.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$44.5 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $769M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...